2013 Q3 Form 10-K Financial Statement

#000005697814000193 Filed on November 12, 2014

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2013 Q1
Revenue $173.6M $141.2M $106.1M
YoY Change -35.5% -44.75% -27.47%
Cost Of Revenue $92.90M $75.27M $57.29M
YoY Change -36.46% -43.44% -28.05%
Gross Profit $80.69M $65.91M $48.82M
YoY Change -34.39% -46.17% -26.79%
Gross Profit Margin 46.48% 46.69% 46.01%
Selling, General & Admin $30.80M $31.26M $28.42M
YoY Change -0.65% 3.7% -6.91%
% of Gross Profit 38.17% 47.43% 58.22%
Research & Development $15.40M $15.78M $12.21M
YoY Change -11.49% -1.47% -23.28%
% of Gross Profit 19.09% 23.94% 25.0%
Depreciation & Amortization $4.200M $2.504M $2.408M
YoY Change -8.7% 33.48% 24.96%
% of Gross Profit 5.21% 3.8% 4.93%
Operating Expenses $46.20M $47.05M $40.63M
YoY Change -8.7% 1.91% -12.52%
Operating Profit $34.54M $18.87M $8.190M
YoY Change -50.88% -75.26% -59.54%
Interest Expense $200.0K $0.00 $1.000K
YoY Change 0.0% -100.0% -99.95%
% of Operating Profit 0.58% 0.0% 0.01%
Other Income/Expense, Net
YoY Change
Pretax Income $34.80M $19.13M $8.377M
YoY Change -50.64% -74.5% -54.06%
Income Tax $5.247M $247.0K $1.041M
% Of Pretax Income 15.08% 1.29% 12.43%
Net Earnings $29.53M $18.89M $7.336M
YoY Change -56.11% -72.3% -55.85%
Net Earnings / Revenue 17.01% 13.38% 6.91%
Basic Earnings Per Share $0.39 $0.25 $0.10
Diluted Earnings Per Share $0.39 $0.25 $0.10
COMMON SHARES
Basic Shares Outstanding 75.28M shares 75.23M shares 75.17M shares
Diluted Shares Outstanding 76.57M shares 76.47M shares 76.55M shares

Balance Sheet

Concept 2013 Q3 2013 Q2 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $525.0M $508.5M $498.6M
YoY Change 19.26% 33.57% 17.01%
Cash & Equivalents $521.8M $508.5M $498.6M
Short-Term Investments $3.300M
Other Short-Term Assets $28.50M $25.40M $22.00M
YoY Change 13.55% 3.25% -9.84%
Inventory $38.14M $48.09M $45.60M
Prepaid Expenses
Receivables $162.7M $147.0M $117.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $754.4M $729.0M $683.4M
YoY Change 5.76% 12.43% 5.43%
LONG-TERM ASSETS
Property, Plant & Equipment $47.54M $32.88M $26.60M
YoY Change 67.16% 28.95% 5.42%
Goodwill $41.55M $41.55M
YoY Change 0.0%
Intangibles $11.21M $13.50M
YoY Change -45.02%
Long-Term Investments
YoY Change
Other Assets $8.310M $9.622M $11.00M
YoY Change -30.28% -9.23% 0.83%
Total Long-Term Assets $108.6M $97.55M $95.00M
YoY Change 6.17% -2.74% -7.47%
TOTAL ASSETS
Total Short-Term Assets $754.4M $729.0M $683.4M
Total Long-Term Assets $108.6M $97.55M $95.00M
Total Assets $863.0M $826.5M $778.4M
YoY Change 5.81% 10.4% 3.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.03M $46.25M $26.40M
YoY Change -35.3% -33.93% -43.73%
Accrued Expenses $23.90M $35.10M $30.30M
YoY Change -2.05% 52.61% 45.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $77.40M $97.73M $70.10M
YoY Change -37.26% -27.66% -66.0%
LONG-TERM LIABILITIES
Long-Term Debt $19.40M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.822M $9.100M $9.000M
YoY Change -17.54% -6.19% -11.3%
Total Long-Term Liabilities $8.822M $9.100M $9.000M
YoY Change -17.54% -6.19% -11.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $77.40M $97.73M $70.10M
Total Long-Term Liabilities $8.822M $9.100M $9.000M
Total Liabilities $146.3M $143.3M $117.2M
YoY Change -14.9% -18.48% -52.81%
SHAREHOLDERS EQUITY
Retained Earnings $289.2M $262.3M
YoY Change 24.39%
Common Stock $467.5M $464.1M
YoY Change 2.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $46.36M $46.36M
YoY Change 0.0%
Treasury Stock Shares 4.954M shares 4.954M shares
Shareholders Equity $714.0M $683.2M $661.2M
YoY Change
Total Liabilities & Shareholders Equity $863.0M $826.5M $778.4M
YoY Change 5.81% 10.4% 3.67%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2013 Q1
OPERATING ACTIVITIES
Net Income $29.53M $18.89M $7.336M
YoY Change -56.11% -72.3% -55.85%
Depreciation, Depletion And Amortization $4.200M $2.504M $2.408M
YoY Change -8.7% 33.48% 24.96%
Cash From Operating Activities $26.60M $11.40M -$1.700M
YoY Change -55.14% -82.81% -107.36%
INVESTING ACTIVITIES
Capital Expenditures -$11.20M -$2.600M -$1.800M
YoY Change 522.22% 18.18% 28.57%
Acquisitions
YoY Change
Other Investing Activities -$3.200M $0.00 $8.200M
YoY Change
Cash From Investing Activities -$14.50M -$2.500M $6.400M
YoY Change 705.56% 13.64% -557.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 800.0K 400.0K 300.0K
YoY Change -57.89% -100.37% -66.67%
NET CHANGE
Cash From Operating Activities 26.60M 11.40M -1.700M
Cash From Investing Activities -14.50M -2.500M 6.400M
Cash From Financing Activities 800.0K 400.0K 300.0K
Net Change In Cash 12.90M 9.300M 5.000M
YoY Change -78.28% -120.48% -77.88%
FREE CASH FLOW
Cash From Operating Activities $26.60M $11.40M -$1.700M
Capital Expenditures -$11.20M -$2.600M -$1.800M
Free Cash Flow $37.80M $14.00M $100.0K
YoY Change -38.13% -79.56% -99.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
171530000 USD
CY2013Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
162714000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
35132000 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
37030000 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1504000 USD
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2488000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
64225000 USD
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65346000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
609000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
227000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3199000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
4182000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3618000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2244000 USD
CY2013 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
825000 USD
CY2014 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-825000 USD
CY2012 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1537000 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8691000 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11336000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10670000 USD
CY2013Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
504000 USD
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
143000 USD
CY2013 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5174000 USD
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2012Q2 us-gaap Area Of Land
AreaOfLand
198000 sqft
CY2013 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2012 us-gaap Asset Impairment Charges
AssetImpairmentCharges
206000 USD
CY2014 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2013Q3 us-gaap Assets
Assets
862994000 USD
CY2014Q3 us-gaap Assets
Assets
944448000 USD
CY2012Q3 us-gaap Assets
Assets
815609000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
754388000 USD
CY2014Q3 us-gaap Assets Current
AssetsCurrent
837691000 USD
CY2014Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
597086000 USD
CY2013Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
525040000 USD
CY2014Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
9105000 USD
CY2013Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3252000 USD
CY2014 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These consolidated financial statements include the accounts of Kulicke and Soffa Industries, Inc. and its subsidiaries (the &#8220;Company&#8221;), with appropriate elimination of intercompany balances and transactions. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of the Company's first three fiscal quarters ends on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks. The </font><font style="font-family:inherit;font-size:10pt;">2014, 2013, and 2012</font><font style="font-family:inherit;font-size:10pt;"> fiscal years ended on </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2014</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">September&#160;28, 2013</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2012</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Nature of Business</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company designs, manufactures and sells capital equipment and expendable tools as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company's operating results depend upon the capital and operating expenditures of semiconductor manufacturers and outsourced semiconductor assembly and test providers (&#8220;OSATs&#8221;) worldwide which, in turn, depend on the current and anticipated market demand for semiconductors and products utilizing semiconductors. The semiconductor industry is highly volatile and experiences downturns and slowdowns which can have a severe negative effect on the semiconductor industry's demand for semiconductor capital equipment, including assembly equipment manufactured and sold by the Company and, to a lesser extent, expendable tools, including those sold by the Company. These downturns and slowdowns have in the past adversely affected the Company's operating results. The Company believes such volatility will continue to characterize the industry and the Company's operations in the future.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, valuation allowances for deferred tax assets and deferred tax liabilities, repatriation of un-remitted foreign subsidiary earnings, equity-based compensation expense, restructuring, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of its assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Vulnerability to Certain Concentrations</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments which may subject the Company to concentrations of credit risk as of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;27, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;28, 2013</font><font style="font-family:inherit;font-size:10pt;"> consisted primarily of short-term investments and trade receivables. The Company manages credit risk associated with investments by investing its excess cash in highly rated debt instruments of the U.S. Government and its agencies, financial institutions, and corporations. The Company has established investment guidelines relative to diversification and maturities designed to maintain safety and liquidity. These guidelines are periodically reviewed and modified as appropriate. The Company does not have any exposure to sub-prime financial instruments or auction rate securities. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's trade receivables result primarily from the sale of semiconductor equipment, related accessories and replacement parts, and expendable tools to a relatively small number of large manufacturers in a highly concentrated industry. Write-offs of uncollectible accounts have historically not been significant; however, the Company monitors its customers' financial strength to reduce the risk of loss. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's products are complex and require raw materials, components and subassemblies having a high degree of reliability, accuracy and performance. The Company relies on subcontractors to manufacture many of these components and subassemblies and it relies on sole source suppliers for some important components and raw material inventory.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's international operations are exposed to changes in foreign currency exchange rates due to transactions denominated in currencies other than the location's functional currency. The Company is also exposed to foreign currency fluctuations that impact the remeasurement of net monetary assets of those operations whose functional currency, the U.S. dollar, differs from their respective local currencies, most notably in Israel, Malaysia, Singapore and Switzerland. In addition to net monetary remeasurement, the Company has exposures related to the translation of subsidiary financial statements from their functional currency, the local currency, into its reporting currency, the U.S. dollar, most notably in China, Taiwan, Japan and Germany. The Company's U.S. operations also have foreign currency exposure due to net monetary assets denominated in currencies other than the U.S. dollar.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The majority of the Company's business is transacted in U.S. dollars; however, the functional currencies of some of the Company's subsidiaries are their local currencies. In accordance with ASC No. 830, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Matters</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 830&#8221;), for a subsidiary of the Company that has a functional currency other than the U.S. dollar, gains and losses resulting from the translation of the functional currency into U.S. dollars for financial statement presentation are not included in determining net income, but are accumulated in the cumulative translation adjustment account as a separate component of shareholders' equity (accumulated other comprehensive income (loss)). Under ASC 830, cumulative translation adjustments are not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Gains and losses resulting from foreign currency transactions are included in the determination of net income.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s primary objective for holding derivative financial instruments is to manage the fluctuation in foreign exchange rates and accordingly is not speculative in nature. The Company&#8217;s international operations are exposed to changes in foreign exchange rates as described above. The Company has established a program to monitor the forecasted transaction currency risk to protect against foreign exchange rate volatility. Generally, the Company uses foreign exchange forward contracts in these hedging programs. The instruments, which have maturities of up to six months, are recorded at fair value and are included in prepaid expenses and other current assets, or other accrued expenses and other current liabilities. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounting policy for derivative financial instruments is based on whether they meet the criteria for designation as a cash flow hedge. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction is referred to as a cash flow hedge. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument&#8217;s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain / (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income / (loss) and reclassify it into earnings in the same period in which the hedged transaction affects earnings and in the same line item on the consolidated statement of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statement of cash flows in the same section as the underlying item, primarily within cash flows from operating activities. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The hedge effectiveness of these derivative instruments is evaluated by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If a cash flow hedge is discontinued because it is no longer probable that the original hedged transaction will occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income / (loss) into earnings. Subsequent gain / (loss) on the related derivative instrument is recognized into earnings in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash Equivalents </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents are measured at fair value based on level one measurement, or quoted market prices, as defined by ASC No. 820, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures</font><font style="font-family:inherit;font-size:10pt;">. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;27, 2014</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">September&#160;28, 2013</font><font style="font-family:inherit;font-size:10pt;">, fair value approximated the cost basis for cash equivalents. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments, other than cash equivalents, are classified as &#8220;trading,&#8221; &#8220;available-for-sale&#8221; or &#8220;held-to-maturity,&#8221; in accordance with ASC No. 320, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Investments-Debt &amp; Equity Securities</font><font style="font-family:inherit;font-size:10pt;">, and depending upon the nature of the investment, its ultimate maturity date in the case of debt securities, and management's intentions with respect to holding the securities. Investments classified as &#8220;trading&#8221; are reported at fair market value, with unrealized gains or losses included in earnings. Investments classified as &#8220;available-for-sale&#8221; are reported at fair market value, with net unrealized gains or losses reflected as a separate component of shareholders' equity (accumulated other comprehensive income (loss)). The fair market value of trading and available-for-sale securities is determined using quoted market prices at the balance sheet date. Investments classified as held-to-maturity are reported at amortized cost. Realized gains and losses are determined on the basis of specific identification of the securities sold.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allowance for Doubtful Accounts</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains allowances for doubtful accounts for estimated losses resulting from its customers' failure to make required payments. If the financial condition of the Company's customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required. The Company is also subject to concentrations of customers and sales to a few geographic locations, which could also impact the collectability of certain receivables. If global economic conditions deteriorate or political conditions were to change in some of the countries where the Company does business, it could have a significant impact on the results of operations, and the Company's ability to realize the full value of its accounts receivable.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost (on a first-in first-out basis) or market value. The Company generally provides reserves for obsolete inventory and for inventory considered to be in excess of demand. Demand is generally defined as </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">18 months</font><font style="font-family:inherit;font-size:10pt;"> forecasted future consumption for equipment, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">24 months</font><font style="font-family:inherit;font-size:10pt;"> forecasted future consumption for all spare parts, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">12 months</font><font style="font-family:inherit;font-size:10pt;"> forecasted future consumption for expendable tools. Forecasted consumption is based upon internal projections, historical sales volumes, customer order activity and a review of consumable inventory levels at customers' facilities. The Company communicates forecasts of its future consumption to its suppliers and adjusts commitments to those suppliers accordingly. If required, the Company reserves the difference between the carrying value of its inventory and the lower of cost or market value, based upon assumptions about future consumption, and market conditions. If actual market conditions are less favorable than projections, additional inventory reserves may be required.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are carried at cost. The cost of additions and those improvements which increase the capacity or lengthen the useful lives of assets are capitalized while repair and maintenance costs are expensed as incurred. Depreciation and amortization are provided on a straight-line basis over the estimated useful lives as follows: buildings </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">25 years</font><font style="font-family:inherit;font-size:10pt;">; machinery and equipment </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10 years</font><font style="font-family:inherit;font-size:10pt;">; and leasehold improvements are </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">based on the shorter of the life of lease or life of asset</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Purchased computer software costs related to business and financial systems are amortized over a five-year period on a straight-line basis.</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Valuation of Long-Lived Assets </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC No. 360, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Property, Plant &amp; Equipment</font><font style="font-family:inherit;font-size:10pt;"> ("ASC 360"), the Company's property, plant and equipment is tested for impairment based on undiscounted cash flows when triggering events occur, and if impaired, written-down to fair value based on either discounted cash flows or appraised values. ASC 360 also provides a single accounting model for long-lived assets to be disposed of by sale and establishes additional criteria that would have to be met to classify an asset as held for sale. The carrying amount of an asset or asset group is not recoverable to the extent it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset or asset group. Estimates of future cash flows used to test the recoverability of a long-lived asset or asset group must incorporate the entity's own assumptions about its use of the asset or asset group and must factor in all available evidence.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC 360 requires that long-lived assets be tested for recoverability whenever events or changes in circumstances indicate that their carrying amount may not be recoverable. Such events include significant under-performance relative to historical internal forecasts or projected future operating results; significant changes in the manner of use of the assets; significant negative industry or economic trends; and significant changes in market capitalization. During the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;27, 2014</font><font style="font-family:inherit;font-size:10pt;"> and September 28, 2013, no triggering events occurred. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting for Impairment of Goodwill</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates two reportable segments: Equipment and Expendable Tools. Goodwill was recorded in 2009 for the acquisition of Orthodyne Electronics Corporation ("Orthodyne"), which added wedge bonder products (also known as "reporting unit") to the Equipment business. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting Standard Update 2011-08, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Testing Goodwill for Impairment (&#8220;ASU 2011-08&#8221;),</font><font style="font-family:inherit;font-size:10pt;"> provides companies with the option to assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.&#160;If, after assessing the qualitative factors, a company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying value, then performing the two-step impairment test is unnecessary.&#160;However, if a company concludes otherwise, then it is required to perform the first step of the two-step goodwill impairment test.&#160;If the carrying value of a reporting unit exceeds its fair value in the first step of the test, then a company is required to perform the second step of the goodwill impairment test to measure the amount of the reporting unit&#8217;s goodwill impairment loss, if any.&#160; </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2013 and 2014, the Company chose to bypass the qualitative assessment and proceed directly to performing the quantitative evaluation of the fair value of the reporting unit, to compare against the carrying value of the reporting unit. </font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of our annual evaluation, the Company performs an impairment test of its goodwill in the fourth quarter of each fiscal year to coincide with the completion of its annual forecasting and refreshing of its business outlook processes. On an ongoing basis, the Company monitors if a &#8220;triggering&#8221; event has occurred that may have the effect of reducing the fair value of a reporting unit below its respective carrying value. Adverse changes in expected operating results and/or unfavorable changes in other economic factors used to estimate fair values could result in a non-cash impairment charge in the future. &#160;&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of September 27, 2014, the Company concluded that the fair value of the Wedge bonder reporting unit exceeded its carrying value. Accordingly, no impairment of goodwill has been recorded. Impairment assessments inherently involve judgment as to assumptions about expected future cash flows and the impact of market conditions on those assumptions. The assumptions include prices, costs, and growth rates. The Company will perform interim goodwill impairment assessments if there are indicators of potential impairment. These include significant and unforeseen customer losses, a significant adverse change in legal factors or in the business climate, a significant adverse action or assessment by a regulator, a significant stock price decline, unforeseen changes in technology or unanticipated competition. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For further information on goodwill and other intangible assets, see Note 3 below.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC No. 605, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">, the Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable, the collectability is reasonably assured, and customer acceptance, when applicable, has been received or we otherwise have been released from customer acceptance obligations. If terms of the sale provide for a customer acceptance period, revenue is recognized upon the expiration of the acceptance period or customer acceptance, whichever occurs first. The Company&#8217;s standard terms are </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ex works</font><font style="font-family:inherit;font-size:10pt;"> (the Company&#8217;s factory), with title transferring to its customer at the Company&#8217;s loading dock or upon embarkation. The Company has a small percentage of sales with other terms, and revenue is recognized in accordance with the terms of the related customer purchase order. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs billed to customers are recognized in net revenue. Shipping and handling costs paid by the Company are included in cost of sales.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company charges research and development costs associated with the development of new products to expense when incurred. In certain circumstances, pre-production machines which the Company intends to sell are carried as inventory until sold.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC No. 740, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">, deferred income taxes are determined using the liability method</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">. </font><font style="font-family:inherit;font-size:10pt;">The Company records a valuation allowance to reduce its deferred tax assets to the amount it expects is more likely than not to be realized. While the Company has considered future taxable income and its ongoing tax planning strategies in assessing the need for the valuation allowance, if it were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made. Likewise, should the Company determine it would not be able to realize all or part of its net deferred tax assets in the future, an adjustment to the deferred tax asset would decrease income in the period such determination was made. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC No. 740 Topic 10, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes, General </font><font style="font-family:inherit;font-size:10pt;">(&#8220;ASC 740.10&#8221;), the Company accounts for uncertain tax positions taken or expected to be taken in its income tax return. Under ASC 740.10, the Company utilizes a two-step approach for evaluating uncertain tax positions. Step one, or recognition, requires a company to determine if the weight of available evidence indicates a tax position is more likely than not to be sustained upon audit, including resolution of related appeals or litigation processes, if any. Step two, or measurement, is based on the largest amount of benefit, which is more likely than not to be realized on settlement with the taxing authority.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Equity-Based Compensation </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for equity-based compensation under the provisions of ASC No. 718,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Compensation - Stock Compensation</font><font style="font-family:inherit;font-size:10pt;"> (&#8220;ASC 718&#8221;). ASC 718 requires the recognition of the fair value of the equity-based compensation in net income. Compensation expense associated with market-based restricted stock is determined using a Monte-Carlo valuation model, and compensation expense associated with time-based and performance-based restricted stock is determined based on the number of shares granted and the fair value on the date of grant. The fair value of the Company's stock option awards are estimated using a Black-Scholes option valuation model. In addition, the calculation of equity-based compensation costs requires that the Company estimate the number of awards that will be forfeited during the vesting period. The fair value of equity-based awards is amortized over the vesting period of the award and the Company elected to use the straight-line method for awards granted after the adoption of ASC 718.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings per share (&#8220;EPS&#8221;) are calculated in accordance with ASC No. 260,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Earnings per Share</font><font style="font-family:inherit;font-size:10pt;">. Basic EPS include only the weighted average number of common shares outstanding during the period. Diluted EPS includes the weighted average number of common shares and the dilutive effect of stock options, restricted stock and share unit awards and convertible subordinated notes outstanding during the period, when such instruments are dilutive.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC No. 260.10.55, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Earnings per Share - Implementation &amp; Guidance</font><font style="font-family:inherit;font-size:10pt;">, the Company treats all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends as participating in undistributed earnings with common shareholders. Awards of this nature are considered participating securities and the two-class method of computing basic and diluted EPS must be applied. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Prior Period Adjustment</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended December 28, 2013, the Company identified a prior period adjustment of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> relating to the provision of input tax receivables that resulted in increased selling, general and administrative expense and a reduction of input tax receivable that should have been recorded during the three months ended September 28, 2013. This error was corrected during the quarter ended December 28, 2013 and management has deemed that the adjustment was not material to the quarter ended September 28, 2013, the fiscal year ended September 28, 2013, or the fiscal year ended September 27, 2014. </font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the three months ended June 28, 2014, the Company identified a prior period adjustment of </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> relating to the pricing discounts given to certain distributors that resulted in the decrease of the selling, general and administrative expense and the revenue that should have been recorded during the six months ended March 29, 2014. This error was corrected during the quarter ended June 28, 2014 and management has assessed that the adjustment was not material to the six months ended March 29, 2014, or the fiscal year ended September 27, 2014.</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (&#8220;ASC&#8221;) 605, Revenue Recognition. The new revenue recognition standard requires entities to recognize revenue in a way that reflects the transfer of promised goods or services to customers in an amount based on the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for interim and annual reporting periods beginning after December 15, 2016 and early adoption is not permitted. The Company is currently assessing the impact of this new guidance.</font></div></div>
CY2013Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
3060000 USD
CY2014Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
31159000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
521788000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
587981000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
440244000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
378188000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
587981000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
521788000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
81544000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
62056000 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
66193000 USD
CY2014Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
597086000 USD
CY2013Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
525040000 USD
CY2014 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2012 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1498000 USD
CY2013 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2014Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81624000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80237000 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76626000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75283000 shares
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
467525000 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
479116000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
60595000 USD
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
61614000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
160417000 USD
CY2014Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
0 USD
CY2013Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
19396000 USD
CY2014 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
295015000 USD
CY2013 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
287993000 USD
CY2012 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
423633000 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
843000 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4103000 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-212000 USD
CY2013 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1732000 USD
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5497000 USD
CY2014 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5534000 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
78000 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
291000 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
942000 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
5474000 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4169000 USD
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
985000 USD
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
2211000 USD
CY2013 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
4509000 USD
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1088000 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3964000 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5901000 USD
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4494000 USD
CY2014Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
2161000 USD
CY2013Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
1097000 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
5000 USD
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
48000 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
5000 USD
CY2014Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29152000 USD
CY2013Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31974000 USD
CY2013Q3 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
3800000 USD
CY2014Q3 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
3800000 USD
CY2014Q3 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
4185000 USD
CY2013Q3 us-gaap Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
4266000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4291000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4487000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
6298000 USD
CY2014Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5308000 USD
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27361000 USD
CY2013Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28138000 USD
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
6900000 USD
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
80600000 USD
CY2014Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
177800000 USD
CY2014Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
400000 USD
CY2013Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
926000 USD
CY2014Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
700000 USD
CY2014Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
703000 USD
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1299000 USD
CY2013Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
3349000 USD
CY2014Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
3713000 USD
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
780000 USD
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance Current
DeferredTaxAssetsValuationAllowanceCurrent
768000 USD
CY2013Q3 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
25676000 USD
CY2014Q3 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
23844000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
32645000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
37024000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
106000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Gross Current
DeferredTaxLiabilitiesGrossCurrent
221000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
46517000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Gross Noncurrent
DeferredTaxLiabilitiesGrossNoncurrent
43209000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
36911000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
41209000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
300000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
0 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1887000 USD
CY2014Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3013000 USD
CY2014Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
2026000 USD
CY2013Q3 us-gaap Defined Benefit Plan Benefit Obligation
DefinedBenefitPlanBenefitObligation
1711000 USD
CY2013 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
2100000 USD
CY2014 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
84000 USD
CY2012 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
1690000 USD
CY2013 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
1700000 USD
CY2014 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements And Curtailments1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
2100000 USD
CY2012 us-gaap Depreciation
Depreciation
8087000 USD
CY2014 us-gaap Depreciation
Depreciation
8202000 USD
CY2013 us-gaap Depreciation
Depreciation
9311000 USD
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18489000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17265000 USD
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13520000 USD
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.82
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.17
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.79
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.13
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-129000 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
109000 USD
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
101000 USD
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.183
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.110
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.078
CY2012 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
8511000 USD
CY2013 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
10670000 USD
CY2014 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
11336000 USD
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
19779000 USD
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21498000 USD
CY2014 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
1100000 USD
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3292 USD
CY2014 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-825000 USD
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
825000 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1537000 USD
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-825000 USD
CY2012 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1537000 USD
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
825000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
573000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5318000 USD
CY2014Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5891000 USD
CY2014 us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Each of the Company's first three fiscal quarters ends on the Saturday that is 13 weeks after the end of the immediately preceding fiscal quarter. The fourth quarter of each fiscal year ends on the Saturday closest to September 30</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">th</sup></font><font style="font-family:inherit;font-size:10pt;">. In fiscal years consisting of 53 weeks, the fourth quarter will consist of 14 weeks.</font></div></div>
CY2014 us-gaap Foreign Earnings Repatriated
ForeignEarningsRepatriated
18200000 USD
CY2013 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
147000 USD
CY2014 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-90000 USD
CY2012 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 USD
CY2013Q3 us-gaap Goodwill
Goodwill
41546000 USD
CY2014Q3 us-gaap Goodwill
Goodwill
41546000 USD
CY2014 us-gaap Gross Profit
GrossProfit
273554000 USD
CY2013 us-gaap Gross Profit
GrossProfit
246945000 USD
CY2012 us-gaap Gross Profit
GrossProfit
367390000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
80686000 USD
CY2012Q4 us-gaap Gross Profit
GrossProfit
51525000 USD
CY2013Q4 us-gaap Gross Profit
GrossProfit
38365000 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
85157000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
65914000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
92360000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
48820000 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
57672000 USD
CY2013Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
3400000 SGD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
7700000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4340000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6111000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
66668000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
77133000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
174251000 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
69433000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1041000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
71008000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
180362000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7310000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13671000 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14145000 USD
CY2013Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-91000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4908000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8241000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
247000 USD
CY2012Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
775000 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5247000 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1087000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1820000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1429000 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1261000 USD
CY2012 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
0 USD
CY2014 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
-8190000 USD
CY2013 us-gaap Income Tax Reconciliation Deductions Dividends
IncomeTaxReconciliationDeductionsDividends
0 USD
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-11193000 USD
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-30067000 USD
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-9763000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
26997000 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
23334000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
60988000 USD
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
964000 USD
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-16000 USD
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1109000 USD
CY2012 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
12604000 USD
CY2014 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
5906000 USD
CY2013 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
1789000 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-394000 USD
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2241000 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-734000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
10854000 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
4603000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
8382000 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14618000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17056000 USD
CY2014 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
9294000 USD
CY2012 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
49111000 USD
CY2013 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-26408000 USD
CY2014 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1030000 USD
CY2012 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
0 USD
CY2014 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
0 USD
CY2012 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6071000 USD
CY2013 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6832000 USD
CY2013 us-gaap Increase Decrease In Asset Retirement Obligations
IncreaseDecreaseInAssetRetirementObligations
-368000 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-8144000 USD
CY2012 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-209000 USD
CY2013 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1769000 USD
CY2014 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-1196000 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8866000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2421000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
46000 USD
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5891000 USD
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11209000 USD
CY2012 us-gaap Interest Expense
InterestExpense
5808000 USD
CY2014 us-gaap Interest Expense
InterestExpense
1048000 USD
CY2013 us-gaap Interest Expense
InterestExpense
21000 USD
CY2014 us-gaap Interest Paid
InterestPaid
1048000 USD
CY2012 us-gaap Interest Paid
InterestPaid
633000 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2014Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22590000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20333000 USD
CY2013Q3 us-gaap Inventory Gross
InventoryGross
52255000 USD
CY2014Q3 us-gaap Inventory Gross
InventoryGross
63557000 USD
CY2014Q3 us-gaap Inventory Net
InventoryNet
49694000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
38135000 USD
CY2013Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
19703000 USD
CY2014Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
22184000 USD
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
13863000 USD
CY2013Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
14120000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
12219000 USD
CY2014Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
18783000 USD
CY2012 us-gaap Inventory Write Down
InventoryWriteDown
6060000 USD
CY2013 us-gaap Inventory Write Down
InventoryWriteDown
3561000 USD
CY2014 us-gaap Inventory Write Down
InventoryWriteDown
3060000 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
1197000 USD
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
883000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
833000 USD
CY2014Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
9105000 USD
CY2013Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
3252000 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7765000 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
4608000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
7202000 USD
CY2013Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15763000 USD
CY2014Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
13962000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
155206000 USD
CY2013Q3 us-gaap Liabilities
Liabilities
146329000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
862994000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
944448000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
77402000 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
81351000 USD
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5000000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1733000 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-164000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-105138000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15114000 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15974000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15386000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
82460000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
182471000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94824000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
183969000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
94824000 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
82460000 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
62988000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
160580000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
59358000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
26616000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
7336000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-1957000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
29531000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
9070000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
18887000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
391000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
370000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
29259000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
3604000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
62988000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
160575000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
59358000 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
160575000 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
59358000 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
62988000 USD
CY2014Q3 us-gaap Noncurrent Assets
NoncurrentAssets
106757000 USD
CY2012Q3 us-gaap Noncurrent Assets
NoncurrentAssets
102293000 USD
CY2013Q3 us-gaap Noncurrent Assets
NoncurrentAssets
108606000 USD
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2013 us-gaap Operating Expenses
OperatingExpenses
181139000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
188164000 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
196570000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
179226000 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
65806000 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
76984000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34544000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4205000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2208000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
31584000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8190000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
37497000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
18867000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
10111000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
29525000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3702000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2584000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3058000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3462000 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
16719000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8310000 USD
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6565000 USD
CY2014Q3 us-gaap Other Commitment
OtherCommitment
113765000 USD
CY2014Q3 us-gaap Other Commitment Due After Fifth Year
OtherCommitmentDueAfterFifthYear
16719000 USD
CY2014Q3 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
2584000 USD
CY2014Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
87942000 USD
CY2014Q3 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
3462000 USD
CY2014Q3 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
3058000 USD
CY2012 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
370000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-51000 USD
CY2013 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-51000 USD
CY2014 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
391000 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
207000 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1186000 USD
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-983000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1237000 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-163000 USD
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1374000 USD
CY2013Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5614000 USD
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8045000 USD
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9790000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8822000 USD
CY2014Q3 us-gaap Payables To Customers
PayablesToCustomers
8999000 USD
CY2013Q3 us-gaap Payables To Customers
PayablesToCustomers
8270000 USD
CY2013 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 USD
CY2014 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0 USD
CY2012 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-6364000 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
419000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2013 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2014 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2013 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14848000 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10138000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6902000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17172000 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
18236000 USD
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3252000 USD
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013 us-gaap Pension Contributions
PensionContributions
1478000 USD
CY2014 us-gaap Pension Contributions
PensionContributions
1278000 USD
CY2014Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2013Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15090000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24012000 USD
CY2014Q3 us-gaap Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions
PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions
19102000 USD
CY2013Q3 us-gaap Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions
PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions
19396000 USD
CY2013Q4 us-gaap Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions
PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions
20000000 USD
CY2014Q1 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
1600000 USD
CY2014 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
800000 USD
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
12356000 USD
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2013 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 USD
CY2012 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-110000000 USD
CY2014 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
5310000 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
44000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
908000 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3325000 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1080000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2245000 USD
CY2014Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1542000 USD
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1194000 USD
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2412000 USD
CY2012 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3354000 USD
CY2014 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1751000 USD
CY2013 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2311000 USD
CY2012 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3521000 USD
CY2013 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1093000 USD
CY2014 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2099000 USD
CY2012 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
6902000 USD
CY2014 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
12401000 USD
CY2013 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
17172000 USD
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
118101000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
111766000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47541000 USD
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52755000 USD
CY2014Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
45442000 USD
CY2013Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
48998000 USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1239000 USD
CY2014 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
320000 USD
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
371000 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
83056000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
63446000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61620000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
291878000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
354866000 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
568569000 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
791023000 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
534938000 USD
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
114039000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
194733000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
141181000 USD
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
180517000 USD
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
79113000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
106110000 USD
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
114206000 USD
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
173608000 USD
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113514000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
119519000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
124718000 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
1
CY2014Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
220000 shares
CY2014Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
8.16
CY2014Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
8.14
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P2Y6M0D
CY2014Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
217000 shares
CY2013Q3 us-gaap Short Term Investments
ShortTermInvestments
3252000 USD
CY2014Q3 us-gaap Short Term Investments
ShortTermInvestments
9105000 USD
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
720000 USD
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
809000 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
840000 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1080000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3325000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
908000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
789242000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
716665000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
643667000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
469877000 USD
CY2013Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
1468000 USD
CY2014Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
1067000 USD
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4954000 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4998000 shares
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
46356000 USD
CY2014Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
460500000 USD
CY2012Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6186000 USD
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
46984000 USD
CY2014 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
628000 USD
CY2012 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
5000 USD
CY2014 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
0 USD
CY2013 us-gaap Undistributed Earnings Allocated To Participating Securities
UndistributedEarningsAllocatedToParticipatingSecurities
0 USD
CY2013Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6869000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13702000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7192000 USD
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1802000 USD
CY2014 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
394000 USD
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
7626000 USD
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
7500000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
0 USD
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2485000 USD
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
110000 USD
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
717000 USD
CY2014Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
7200000 USD
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements requires management to make assumptions, estimates and judgments that affect the reported amounts of assets and liabilities, net revenue and expenses during the reporting periods, and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. On an ongoing basis, management evaluates estimates, including but not limited to, those related to accounts receivable, reserves for excess and obsolete inventory, carrying value and lives of fixed assets, goodwill and intangible assets, valuation allowances for deferred tax assets and deferred tax liabilities, repatriation of un-remitted foreign subsidiary earnings, equity-based compensation expense, restructuring, and warranties. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable. As a result, management makes judgments regarding the carrying values of its assets and liabilities that are not readily apparent from other sources. Authoritative pronouncements, historical experience and assumptions are used as the basis for making estimates, and on an ongoing basis, management evaluates these estimates. Actual results may differ from these estimates.</font></div></div>
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75502000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76190000 shares
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77292000 shares
CY2012Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76209000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76473000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76565000 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77605000 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77021000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76553000 shares
CY2013Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75912000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
77925000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76396000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75132000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73887000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75166000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75279000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75231000 shares
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76404000 shares
CY2013Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75912000 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76596000 shares
CY2012Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74852000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76658000 shares
CY2014Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
43731000 USD
CY2013Q3 klic Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
38868000 USD
CY2014Q3 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
1961000 USD
CY2013Q3 klic Accrued Liabilities For Commission And Professional Fees Current
AccruedLiabilitiesForCommissionAndProfessionalFeesCurrent
2640000 USD
CY2014Q3 klic Accumulated Other Comprehensive Income Loss Curtailment Of Pension And Other Postretirement Benefit Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCurtailmentOfPensionAndOtherPostretirementBenefitPlansNetOfTax
346000 USD
CY2013Q3 klic Accumulated Other Comprehensive Income Loss Curtailment Of Pension And Other Postretirement Benefit Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCurtailmentOfPensionAndOtherPostretirementBenefitPlansNetOfTax
337000 USD
CY2014Q3 klic Deferred Tax Assets Net Operating Loss Carryfoward Current
DeferredTaxAssetsNetOperatingLossCarryfowardCurrent
666000 USD
CY2013Q3 klic Deferred Tax Assets Net Operating Loss Carryfoward Current
DeferredTaxAssetsNetOperatingLossCarryfowardCurrent
779000 USD
CY2014Q3 klic Deferred Tax Assets Tax Credit Carryforwards Domestic
DeferredTaxAssetsTaxCreditCarryforwardsDomestic
688000 USD
CY2013Q3 klic Deferred Tax Assets Tax Credit Carryforwards Domestic
DeferredTaxAssetsTaxCreditCarryforwardsDomestic
1611000 USD
CY2013Q3 klic Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Inventory Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsInventoryReserves
1127000 USD
CY2014Q3 klic Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Inventory Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsInventoryReserves
692000 USD
CY2013Q3 klic Deferred Tax Liabilities Net Excluding Other Deferred Tax Assets Noncurrent
DeferredTaxLiabilitiesNetExcludingOtherDeferredTaxAssetsNoncurrent
40709000 USD
CY2014Q3 klic Deferred Tax Liabilities Net Excluding Other Deferred Tax Assets Noncurrent
DeferredTaxLiabilitiesNetExcludingOtherDeferredTaxAssetsNoncurrent
44963000 USD
CY2014Q3 klic Deferred Tax Liabilities Repatriation Of Foreign Earnings Including Foreign Withholding Taxes
DeferredTaxLiabilitiesRepatriationOfForeignEarningsIncludingForeignWithholdingTaxes
43204000 USD
CY2013Q3 klic Deferred Tax Liabilities Repatriation Of Foreign Earnings Including Foreign Withholding Taxes
DeferredTaxLiabilitiesRepatriationOfForeignEarningsIncludingForeignWithholdingTaxes
41322000 USD
CY2014 klic Defined Benefit Plan Employer Contribution Percentage Match Of Compensation
DefinedBenefitPlanEmployerContributionPercentageMatchOfCompensation
employee contributions and matching Company contributions up to 4% or 6%
CY2012 klic Income Tax Reconciliation Effect Of Permanent Items
IncomeTaxReconciliationEffectOfPermanentItems
152000 USD
CY2014 klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-1269000 USD
CY2013 klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
-36066000 USD
CY2012 klic Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
33550000 USD
CY2014 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Marketbased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsMarketbasedRestrictedStock
381000 shares
CY2013 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Marketbased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsMarketbasedRestrictedStock
436000 shares
CY2012 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Marketbased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsMarketbasedRestrictedStock
142000 shares
CY2013 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Stock Options
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsStockOptions
110000 shares
CY2014 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Stock Options
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsStockOptions
117000 shares
CY2014 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.01
CY2012 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.04
CY2013 klic Earnings Per Share Diluted Adjustment
EarningsPerShareDilutedAdjustment
-0.01
CY2014Q3 klic Equipment And Software Gross
EquipmentAndSoftwareGross
27538000 USD
CY2013Q3 klic Equipment And Software Gross
EquipmentAndSoftwareGross
24549000 USD
CY2014 klic Grant To Non Employee Director
GrantToNonEmployeeDirector
120000 USD
CY2014Q3 klic Grant To Non Employee Director
GrantToNonEmployeeDirector
30000 USD
CY2012 klic Income Tax Reconciliation Benefits From Foreign Approved Enterprises
IncomeTaxReconciliationBenefitsFromForeignApprovedEnterprises
22138000 USD
CY2014 klic Income Tax Reconciliation Benefits From Foreign Approved Enterprises
IncomeTaxReconciliationBenefitsFromForeignApprovedEnterprises
17423000 USD
CY2013 klic Income Tax Reconciliation Benefits From Foreign Approved Enterprises
IncomeTaxReconciliationBenefitsFromForeignApprovedEnterprises
9626000 USD
CY2013 klic Income Tax Reconciliation Effect Of Permanent Items
IncomeTaxReconciliationEffectOfPermanentItems
664000 USD
CY2014 klic Income Tax Reconciliation Effect Of Permanent Items
IncomeTaxReconciliationEffectOfPermanentItems
-298000 USD
CY2012 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Stock Options
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsStockOptions
660000 shares
CY2013 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Timebased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsTimebasedRestrictedStock
512000 shares
CY2014 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Timebased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsTimebasedRestrictedStock
398000 shares
CY2012 klic Incremental Common Shares Attributableto Dilutive Effectof Sharebased Payment Arrangements Timebased Restricted Stock
IncrementalCommonSharesAttributabletoDilutiveEffectofSharebasedPaymentArrangementsTimebasedRestrictedStock
813000 shares
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due
InventoryPurchaseObligationFutureMinimumPaymentsDue
84240000 USD
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due Current
InventoryPurchaseObligationFutureMinimumPaymentsDueCurrent
84240000 USD
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Four Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInFourYears
0 USD
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Three Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInThreeYears
0 USD
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due In Two Years
InventoryPurchaseObligationFutureMinimumPaymentsDueInTwoYears
0 USD
CY2014Q3 klic Inventory Purchase Obligation Future Minimum Payments Due Thereafter
InventoryPurchaseObligationFutureMinimumPaymentsDueThereafter
0 USD
CY2014 klic Lease Expiration Year
LeaseExpirationYear
2023
CY2013 klic Number Of Employees Included In Workforce Reduction Plan
NumberOfEmployeesIncludedInWorkforceReductionPlan
41 employee
CY2012Q2 klic Percentage Of Building Area Agreed To Lease From Landlord
PercentageOfBuildingAreaAgreedToLeaseFromLandlord
0.70
CY2014 klic Period Of Warranty For Manufacturing Defects
PeriodOfWarrantyForManufacturingDefects
P1Y
CY2012 klic Selling General And Administrative Incentive Compensation Expense
SellingGeneralAndAdministrativeIncentiveCompensationExpense
21988000 USD
CY2014 klic Relative Total Shareholder Return Average Stock Price Calculation Period
RelativeTotalShareholderReturnAverageStockPriceCalculationPeriod
P90D
CY2014Q3 klic Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
2100000 USD
CY2012 klic Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
-7626000 USD
CY2013 klic Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
683000 USD
CY2014 klic Reserve For Uncertain Tax Positions
ReserveForUncertainTaxPositions
131000 USD
CY2013 klic Selling General And Administrative Incentive Compensation Expense
SellingGeneralAndAdministrativeIncentiveCompensationExpense
17194000 USD
CY2014 klic Selling General And Administrative Incentive Compensation Expense
SellingGeneralAndAdministrativeIncentiveCompensationExpense
17596000 USD
CY2014 klic Share Based Compensation Arrangement By Share Based Payment Award Option Forfeited Vesting Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeitedVestingPercentage
0.22
CY2014 klic Share Based Compensation Arrangement By Share Based Payment Award Option Granted Vesting Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionGrantedVestingPercentage
0.10
CY2014 klic Share Based Compensation Arrangement By Share Based Payment Award Options Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingPeriod
P3Y
CY2012 klic Stock Based Compensation
StockBasedCompensation
7791000 USD
CY2014 klic Stock Based Compensation
StockBasedCompensation
10527000 USD
CY2013 klic Stock Based Compensation
StockBasedCompensation
9830000 USD
CY2012 klic Tax Expense Related To Distributions From Earnings
TaxExpenseRelatedToDistributionsFromEarnings
3000000 USD
CY2014 klic Tax Expense Related To Distributions From Earnings
TaxExpenseRelatedToDistributionsFromEarnings
1200000 USD
CY2013 klic Tax Expense Related To Distributions From Earnings
TaxExpenseRelatedToDistributionsFromEarnings
300000 USD
CY2014Q3 klic Undistributed Earnings Not Reinvested In Foreign Operations
UndistributedEarningsNotReinvestedInForeignOperations
89600000 USD
CY2012 klic Warranty And Retrofit Expense
WarrantyAndRetrofitExpense
3726000 USD
CY2013 klic Warranty And Retrofit Expense
WarrantyAndRetrofitExpense
711000 USD
CY2014 klic Warranty And Retrofit Expense
WarrantyAndRetrofitExpense
3261000 USD
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-27
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-09-27
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0000056978
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76988338 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2014Q1 dei Entity Public Float
EntityPublicFloat
1001800000 USD
CY2014 dei Entity Registrant Name
EntityRegistrantName
KULICKE & SOFFA INDUSTRIES INC
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Trading Symbol
TradingSymbol
klic

Files In Submission

Name View Source Status
0000056978-14-000193-index-headers.html Edgar Link pending
0000056978-14-000193-index.html Edgar Link pending
0000056978-14-000193.txt Edgar Link pending
0000056978-14-000193-xbrl.zip Edgar Link pending
a10k2014.htm Edgar Link pending
exhibit212014.htm Edgar Link pending
exhibit232014.htm Edgar Link pending
exhibit3112014.htm Edgar Link pending
exhibit3122014.htm Edgar Link pending
exhibit3212014.htm Edgar Link pending
exhibit3222014.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
klic-20140927.xml Edgar Link completed
klic-20140927.xsd Edgar Link pending
klic-20140927_cal.xml Edgar Link unprocessable
klic-20140927_def.xml Edgar Link unprocessable
klic-20140927_lab.xml Edgar Link unprocessable
klic-20140927_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending